Home/Filings/4/0001127602-24-018705
4//SEC Filing

ABERCROMBIE GEORGE B 4

Accession 0001127602-24-018705

CIK 0000882796other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:18 PM ET

Size

7.0 KB

Accession

0001127602-24-018705

Insider Transaction Report

Form 4
Period: 2024-06-12
Transactions
  • Award

    Common Stock

    2024-06-12+6,82036,431 total
  • Award

    Automatic Stock Option Grant

    2024-06-12+49,93349,933 total
    Exercise: $6.30From: 2025-06-12Exp: 2034-06-12Common Stock (49,933 underlying)
Footnotes (2)
  • [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
  • [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001485939

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:18 PM ET
Size
7.0 KB